Looking ahead to 2002, HUPO President Sam Hanash told ProteoMonitor he expects the coming year to be critical both for proteomics companies and the organization he leads, as the two try to prove they can live up to their potential.
Looking ahead to 2002, HUPO President Sam Hanash told ProteoMonitor he expects the coming year to be critical both for proteomics companies and the organization he leads, as the two try to prove they can live up to their potential.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.